A personalised vaccine against melanoma can more than double the survival
rate for patients with the advanced form of this skin cancer. Doctors at
Jefferson Medical College in Philadelphia create customised vaccines from
patients’ own cancer cells by inactivating them and altering their surface
proteins with dinitrophenol. Five-year survival rates in 214 patients with
advanced disease increased from around 20 per cent to 50 per cent and a
randomised phase III trial of 400 patients across the US is planned.
To continue reading, today with our introductory offers
Advertisement
More from New ÒÁÈ˾þÃ
Explore the latest news, articles and features
Popular articles
Trending New ÒÁÈ˾þà articles
1
The world's fastest spider tops 3.5 metres per second
2
Babies are born with the neural foundations for maths
3
Where, when and how to watch the 2026 solar eclipse
4
I’m the first person whose life was saved by CRISPR base editing
5
US government wants to have a useful quantum computer by 2028
6
This physicist is hunting for the biggest black hole in the universe
7
Our verdict on The Selfish Gene: An unpopular piece of popular science
8
Europe’s heatwave is the hottest and most humid ever
9
If you aren't terrified by this heatwave, you should be
10
The race to understand how and when Thwaites glacier will collapse
